Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1838 2
1839 1
1840 1
1842 1
1855 3
1859 1
1863 2
1879 1
1961 1
1962 2
1964 1
1965 3
1966 4
1967 1
1968 1
1969 3
1970 3
1971 4
1972 1
1974 4
1975 1
1976 2
1977 1
1978 2
1979 2
1980 2
1981 1
1983 3
1984 6
1985 1
1986 8
1987 6
1988 5
1989 3
1990 6
1991 8
1992 2
1993 10
1994 5
1995 4
1996 7
1997 4
1998 6
1999 7
2000 13
2001 10
2002 5
2003 4
2004 9
2005 7
2006 14
2007 8
2008 10
2009 14
2010 14
2011 10
2012 9
2013 15
2014 7
2015 13
2016 12
2017 15
2018 9
2019 10
2020 10
2021 14
2022 10
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

375 results

Results by year

Filters applied: . Clear all
Page 1
Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221).
Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, Kelly KM, Cannioto R, Sucheston-Campbell LE, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Budd GT, Albain KS. Ambrosone CB, et al. Among authors: budd gt. J Clin Oncol. 2020 Mar 10;38(8):804-814. doi: 10.1200/JCO.19.01203. Epub 2019 Dec 19. J Clin Oncol. 2020. PMID: 31855498 Free PMC article. Clinical Trial.
Physical Activity Before, During, and After Chemotherapy for High-Risk Breast Cancer: Relationships With Survival.
Cannioto RA, Hutson A, Dighe S, McCann W, McCann SE, Zirpoli GR, Barlow W, Kelly KM, DeNysschen CA, Hershman DL, Unger JM, Moore HCF, Stewart JA, Isaacs C, Hobday TJ, Salim M, Hortobagyi GN, Gralow JR, Albain KS, Budd GT, Ambrosone CB. Cannioto RA, et al. Among authors: budd gt. J Natl Cancer Inst. 2021 Jan 4;113(1):54-63. doi: 10.1093/jnci/djaa046. J Natl Cancer Inst. 2021. PMID: 32239145 Free PMC article.
Multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART).
Wagner MJ, Othus M, Patel SP, Ryan C, Sangal A, Powers B, Budd GT, Victor AI, Hsueh CT, Chugh R, Nair S, Leu KM, Agulnik M, Sharon E, Mayerson E, Plets M, Blanke C, Streicher H, Chae YK, Kurzrock R. Wagner MJ, et al. Among authors: budd gt. J Immunother Cancer. 2021 Aug;9(8):e002990. doi: 10.1136/jitc-2021-002990. J Immunother Cancer. 2021. PMID: 34380663 Free PMC article. Clinical Trial.
Morphospace.
Budd GE. Budd GE. Curr Biol. 2021 Oct 11;31(19):R1181-R1185. doi: 10.1016/j.cub.2021.08.040. Curr Biol. 2021. PMID: 34637728 Free article.
Amyloid Degeneration.
Budd G. Budd G. Br Med J. 1879 May 3;1(957):659. doi: 10.1136/bmj.1.957.659. Br Med J. 1879. PMID: 20749189 Free PMC article. No abstract available.
Management of angiosarcoma.
Budd GT. Budd GT. Curr Oncol Rep. 2002 Nov;4(6):515-9. doi: 10.1007/s11912-002-0066-3. Curr Oncol Rep. 2002. PMID: 12354365 Review.
The origin and evolution of the euarthropod labrum.
Budd GE. Budd GE. Arthropod Struct Dev. 2021 May;62:101048. doi: 10.1016/j.asd.2021.101048. Epub 2021 Apr 13. Arthropod Struct Dev. 2021. PMID: 33862532 Free article. Review.
Can CDK4/6 inhibitors cause fatal lung injury?
Jazieh KA, Budd GT, Dalpiaz N, Abraham J. Jazieh KA, et al. Among authors: budd gt. Expert Rev Anticancer Ther. 2019 Nov;19(11):917-919. doi: 10.1080/14737140.2019.1674651. Epub 2019 Oct 8. Expert Rev Anticancer Ther. 2019. PMID: 31566017 No abstract available.
375 results